Iterum Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Iterum Therapeutics (NASDAQ:ITRM) is set to release its latest quarterly earnings report on August 11, 2023. Analysts estimate an earnings per share (EPS) of $-0.80. The company's past performance shows a mixed trend in EPS and price change. The stock was trading at $1.02 as of August 09, with a 52-week return of -74.88%.
August 10, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Iterum Therapeutics is expected to report an EPS of $-0.80 in its upcoming earnings. The stock has been on a downward trend with a 52-week return of -74.88%.
The company's stock has been on a downward trend, which indicates bearish sentiment among investors. The expected negative EPS could further impact the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100